A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 118
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HSV-2
Long Form : HSV type 2
No. Year Title Co-occurring Abbreviation
2022 Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1. CHO, HCE, HSV-1
2021 Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by Interacting with p65. gD, HIV-1, HVEM, IKKalpha, IRF3, TRAF2
2021 Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection. OPTN
2020 An adult case of parainfectious optic neuritis associated with genital herpes simplex virus type 2 infection. ARN, HSV
2020 Herpes Simplex Virus Type 2 Inhibits Type I IFN Signaling Mediated by the Novel E3 Ubiquitin Protein Ligase Activity of Viral Protein ICP22. IRF9, ISGF3, ISGs
2020 The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. GUD, HSV, HSV-1
2020 The presence and impact of herpes virus DNA in recipient cornea and aqueous humor on graft survival following penetrating keratoplasty. CMV, HSV-1, PCR, PKP
2019 High level antibodies to TORCH in the IVIG preparation from Taiwanese. Abs, CMV, EBV, HSV, HSV-1, IgG, IgM, IVIG
2019 Unusual manifestation of disseminated herpes simplex virus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocytic lymphohisitocytosis without genital involvement. HSV, PCR
10  2017 The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase. HIV, HSV, HSV-1
11  2016 Evaluation of a transcription mediated amplification assay for detection of herpes simplex virus types 1 and 2 mRNA in clinical specimens. HHVs, HSV, HSV-1, NAAT, TMA
12  2016 In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol. ACV, HSV-1, MFPT
13  2015 Low prevalences of HIV infection and HSV genital shedding in the general adult female population in Senegal. HIV, HSV, HSV-1, PCR
14  2014 Animal models of herpes simplex virus immunity and pathogenesis. HSV
15  2012 Neonatal herpes simplex virus infection following Jewish ritual circumcisions that included direct orogenital suction - New York City, 2000-2011. DOHMH, HSV, HSV-1
16  2012 Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. ---
17  2011 Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers). HSV
18  2011 Herpes simplex encephalitis : from virus to therapy. HSE, HSV, HSV-1
19  2010 Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. LCs
20  2010 Solvent-induced virus inactivation by acidic arginine solution. HSV
21  2009 Cell type-specific induction and inhibition of apoptosis by Herpes Simplex virus type 2 ICP10. HSV
22  2009 Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55. ELISA, HSV, IgG
23  2009 Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions. HSV, Nedd4, TGN
24  2009 Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. HK, HSV, PCR, PKP, VZV
25  2008 Comparison of nested-polymerase chain reaction and virus culture for the diagnosis of genital herpes simplex virus infection. HSV, HSV-1, PCR, STI
26  2008 The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. HSV-1, PCR, TSS
27  2007 B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice. HSV
28  2007 Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells. HSV
29  2007 Two patients with the von Szily reaction: herpetic keratitis and contralateral retinal necrosis. ARN, HSV
30  2006 Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function. HSV, mAbs
31  2006 Herpes simplex virus and the chemokines that mediate the inflammation. HIV, HSV, HSV-1
32  2006 Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes. CLA, HSV, PBMC
33  2006 Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania. GUS, HSV, STI
34  2006 Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains. HSV, RFLP
35  2006 Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study. HSV
36  2005 Development of herpes simplex virus disease in patients who are receiving cidofovir. ARA, HSV, IC50
37  2005 Herpes simplex virus in pregnancy: new concepts in prevention and management. HSV
38  2005 High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients. HIV-1, HSV
39  2005 Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. NK1R, SP
40  2005 US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles. HSV, PK
41  2004 Once-daily valacyclovir to reduce the risk of transmission of genital herpes. HSV
42  2004 Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay. ELISA, gG, HSV
43  2004 Recommendations for the selective use of herpes simplex virus type 2 serological tests. HIV, HSV, STD
44  2003 An international external quality assessment of nucleic acid amplification of herpes simplex virus. HSV, HSV-1, NAT, PCR
45  2003 Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. HSV, HSV-1, HWBP
46  2003 Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. CSF, HSV
47  2003 Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. HSV, IVAG, vhs
48  2002 Identification and characterization of the UL56 gene product of herpes simplex virus type 2. HSV
49  2002 Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge. HSV
50  2002 Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient. HIV, HSV, pol, TK
51  2002 Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. HSV, HSV-1
52  2002 Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. HSV
53  2002 Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. ELISA, HSV-1
54  2001 Prospective study of pathogen burden and risk of myocardial infarction or death. CAD, CMV, CRP, HAV, HSV-1, MI
55  2001 The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice. HSV, LAT, TG, WT
56  2001 The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. PI
57  2001 [Intrauterine herpes simplex virus infection]. HSV
58  2000 Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. CAD, CMV, CRP, HAV, HSV-1, IgG
59  2000 First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. gG-2, HSV, HSV-1
60  2000 Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. HIV, HSV, HSV-1
61  2000 Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo. CTL, HSV, IgG1, IL-7
62  2000 Memory-type CD8+ T cells protect IL-2 receptor alpha-deficient mice from systemic infection with herpes simplex virus type 2. ---
63  2000 Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment]. HSV
64  1999 A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. HSV, HSV-1
65  1999 Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. CSF, gB, HSV
66  1999 Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice. HSV, HSV-1
67  1999 Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. gG-2, HSV
68  1999 Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. CSF, HSV, VZV
69  1999 The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies. EIA, HSV, HSV-1, IgG
70  1998 Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. HSV, MRI, PCR
71  1998 Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. HSV-1, ICP47, TAP
72  1998 Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs. HSV
73  1998 The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. HSV, IE, PK, RR
74  1997 In vitro inactivation of herpes simplex virus by a biological response modifier, PSK. HSV, HSV-1
75  1997 Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. CMV, HSV, HSV-1
76  1996 Acquired immunodeficiency syndrome--associated herpes simplex virus retinitis. Clinical description and use of a polymerase chain reaction--based assay as a diagnostic tool. HSV, HSV-1, PCR
77  1995 Comparative studies of types 1 and 2 herpes simplex virus infection of cultured normal keratinocytes. HSV, HSV-1
78  1995 Virologic characteristics of subclinical and symptomatic genital herpes infections. HSV, HSV-1
79  1994 Epidemiology of genital herpes. HIV, HSV, HSV-1
80  1994 Rapid immunoassay for the detection of genital herpes infection. HSV
81  1994 Selected epidemiological features of herpes genitalis in Israel based on laboratory data. GMT, HSV, HSV-1
82  1993 Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. HSV
83  1993 Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity. ACV, HSV, TK
84  1991 A related epitope is consistently present on glycoprotein C of herpes simplex virus type 1 and 2. HSV-1
85  1991 Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2. HSV, TK
86  1991 Evaluation of five monoclonal antibody-based kits or reagents for the identification and culture confirmation of herpes simplex virus. HSV, HSV-1, IF
87  1991 Seroepidemiology of herpes simplex virus and restriction endonuclease cleavages analysis of herpes simplex virus type 2 in Okinawa. HSV
88  1988 Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. HSV-1
89  1988 Secretory IgA against herpes simplex virus in cervical secretions. HSV, sIgA, STD
90  1988 Specific induction of cellular gene transcription in herpes simplex virus type 2-transformed cells. HSV
91  1988 Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. HSV, HSV-1
92  1987 Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. CTL, HSV
93  1987 Effects on infants of a first episode of genital herpes during pregnancy. HSV
94  1987 Histopathologic characteristics of two forms of experimental herpes simplex virus retinitis. HSV-1
95  1987 Typing of herpes simplex virus types 1 and 2 by immunoblotting analysis using polyclonal antisera to herpes simplex virus glycoproteins. HSV, HSV-1
96  1985 Evaluation of two immunofluorescence assays with monoclonal antibodies for typing of herpes simplex virus. HSV
97  1985 Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines. HSV, MAF
98  1985 Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine. HSV
99  1985 Immunoperoxidase staining for the detection of herpes simplex virus antigen in cervicovaginal smears. HSV, PAP
100  1985 Inhibition of herpes simplex virus replication in vitro by human cytotoxic T cell clones and natural killer cell clones. CTL, HSV, HSV-1, NK